[Chugin Capital Partners] Regarding the investment decision by Chugin Infinity Fund No. 2 in xCARE Co., Ltd.
*View in browser* *The Chugoku Bank, Ltd.*
Press release: February 13, 2024
**
Regarding the investment decision by Chugin Infinity Fund No. 2 in xCARE Co., Ltd.
Chugin Capital Partners (9th floor, Chugin Main Store Building, 1-15-20 Marunouchi, Kita-ku, Okayama City Representative Director Kobashi)
xCARE Co., Ltd. (Shibuya-ku, Tokyo, Representative Director Fukunaga) is investing in startups through the Chugin Infinity Fund No. 2. We underwrote a third-party allotment of new capital from xCARE (hereinafter “xCARE”).
xCARE provides “xCARE”, an expert platform that introduces project management services necessary for development projects such as pharmaceuticals and medical devices, as well as related expert human resources. Our main clients are bio-ventures, medical device manufacturers, etc. both domestically and internationally, and we provide support from a human perspective for each company’s
commercialization efforts, shortening the time it takes to
commercialize products and increasing the probability of success in product development. Contributing.
The management issue of the medical industry is that a high level of expertise and specialized human resources are required in a wide range of areas, starting with business strategy and basic research, and extending to manufacturing and sales. In particular, new drug development generally takes more than 10 years and often involves a large amount of development funds, making it a major challenge for bioventures and academia.
On the other hand, the use of outsourcing in the development and research processes of pharmaceuticals and medical devices is increasing year by year, and we are also seeing companies taking up the use of optimal external experts according to the development stage as a new management issue.
xCARE’s management team is comprised of members with a high level of expertise and track record in the human resources and medical fields, as well as a wealth of global experience. We are familiar with the project management and optimal staffing methods required to carry out development projects for pharmaceuticals, medical devices, etc., and are able to provide services that meet the needs of our clients.
We hope that by improving the probability of product success and shortening the time to commercialization, more people will be able to enjoy the benefits of new medical treatments and create a world where they can live with peace of mind.
The Chugin Group is a startup that delivers innovation and new value to the region.
Through collaboration with Up, we will work towards further
development of the local community.
*1. Investment project overview*
Investee name (head office location) xCARE Co., Ltd. (Shibuya-ku, Tokyo) Representative Masaru Fukunaga
Establishment date: January 31, 2022
Business content: Building a specialized human resource platform specialized in the pharmaceutical and medical device industries and supporting the implementation of development projects
Homepage Corporate: https://www.xcare-medical.com/
Service: https://xcareplatform.com/
* [Comment from Masashi Fukunaga, Representative Director and CEO of xCARE Co., Ltd.] *
We would like to express our sincere gratitude to Chugin Capital Partners for their investment.
Our company, xCARE, has built an expert platform specializing in the pharmaceutical and medical device industry (medical industry), and registered human resources are actively involved in various projects to commercialize medical products such as bio-ventures, medical device manufacturers, and academia around the world. We are aiming for a system that can achieve this goal. In particular, there are many wonderful medical seeds created by researchers in Japanese academia. Our mission is to create a system where those seeds become solid products and reach the hands of patients.
Many academia are active in the Chugoku-Shikoku region as well. By working together with Chugin Capital Partners, we would like to deepen our collaboration with academia in the Chugoku and Shikoku regions and create a system that can contribute to the innovation of medical products in this region.
that’s all
*About details about this release*
https://prtimes.jp/main/html/rd/p/000000411.000068743.html
*Download press release materials*
https://prtimes.jp/im/action.php?run=html&page=releaseimage&company_id=68743&release_id=411